Deva Holding AS is a Turkey-based pharmaceutical company that is primarily engaged in the production and marketing of finished pharmaceutical products, pharmaceutical ingredients and veterinary products, as well as animal health products, among others. The Company has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company's product portfolio comprises 73 drugs, which are available on the market in 177 various forms. It offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The Company has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

Pharmaceutical

DEVA

This department manages and oversees activities related to hematology and oncology services.

Hematology Operations

This department focuses on the research and development of analytical methods and tools to support product innovation and quality assurance.

Analytical Development

This department manages regulatory compliance and oversees the approval processes for products in international markets.

Regulatory Affairs

This department focuses on driving sales of products and services in both general and medical markets.

Sales and Medical Sales

This department focuses on managing and developing business operations and projects across various international markets.

International Markets

This department focuses on innovating and improving products through scientific research and technical development.

Research and Development

This department ensures the quality and reliability of products and services through systematic evaluation and monitoring processes.

People (2)

Jobs (0)

Other teams

Analytical Development

Regulatory Affairs

Sales and Medical Sales

International Markets

Research and Development

Quality Assurance and Control